Molecular Detection of Breast Cancer Cells in the Peripheral Blood of Advanced-Stage Breast Cancer Patients Using Multimarker Real-Time Reverse Transcription-Polymerase Chain Reaction and a Novel Porous Barrier Density Gradient Centrifugation Technology

Clinical Cancer Research

Volumn 9, Issue 13, 2003, Pages 4865-4871

  Baker, Megan K ^a   Mikhitarian, Kaidi ^a   Osta, Walid ^a   Callahan, Kathi ^a   Hoda, Rana ^a   Brescia, Frank ^a   Kneuper Hall, Rayna ^a   Mitas, Michael ^a   Cole, David J ^a   Gillanders, William E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD CYTOLOGY; BREAST CANCER; CANCER CELL; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CANCER STAGING; CELL ASSAY; CELL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DNA DETERMINATION; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MARKER GENE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TECHNIQUE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CENTRIFUGATION, DENSITY GRADIENT; DNA, COMPLEMENTARY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM CIRCULATING CELLS; PILOT PROJECTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 10744225459     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Valgussa, P., Bonadonna, G., and Veronesi, U. Patterns of relapse and survival following radical mastectomy. Cancer (Phila.), 41: 1170-1178, 1978.
2. Gardner, B., and Feldman, J. Are positive axillary nodes in breast cancer markers for incurable disease? Ann. Surg., 218: 270-277, 1993.
3. Berns, E. M., Klijn, J. G., van Putten, W. L., van Staveren, I. L., Portengen, H., and Foekens, J. A. C-myc amplification is a better prognostic factor than her2/neu amplification in primary breast cancer. Cancer Res., 52: 1107-1113, 1992.
4. Datta, Y. H., Adams, P. T., Drobyski, W. R., Ethier, S. P., Terry, V. H., and Roth, M. S. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol., 12: 475-482, 1994.
5. Gasparini, G., Toi, M., Gion, M., Verderio, P., Dittadi, R., Hanatani, M., Matsubara, I., Vinante, O., Bonoldi, E., Boracchi, P., Gatti, C., Suzuki, H., and Tominaga, T. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. Natl. Cancer Inst. (Bethesda), 89: 139-147, 1997.
6. Ioachim, E., Kamina, S., Athanassiadou, S., and Agnantis, N. J. The prognostic significance of epidermal growth factor receptor (EGFR), c-erbB-2, Ki-67 and PCNA expression in breast cancer. Anticancer Res., 16: 3141-3147, 1996.
7. Anan, K., Morisaki, T., Katano, M., Ikubo, A., Tsukahara, Y., Kojima, M., Uchiyama, A., Kuroki, S., Torisu, M., and Tanaka, M. Assessment of c-erbB2 and vascular endothelial growth factor mMRNA expression in fine-needle aspirates from early breast carcinomas: preoperative determination of malignant potential. Eur. J. Surg. Oncol., 24: 28-33, 1998.
8. Bieche, I., Lazar, V., Nogues, C., Poynard, T., Giovangrandi, Y., Bellet, D., Lidereau, R., and Vidaud, M. Prognostic value of chorionic gonadotropin β gene transcripts in human breast carcinoma. Clin. Cancer Res., 4: 671-676, 1998.
9. Harbeck, N., Dettmar, P., Thomssen, C., Henselmann, B., Kuhn, W., Ulm, K., Janicke, F., Hofler, H., Graeff, H., and Schmitt, M. Prognostic impact of tumor biological factors on survival in node-negative breast cancer. Anticancer Res., 18: 2187-2197, 1998.
10. Linderholm, B., Tavelin, B., Grankvist, K., and Henriksson, R. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J. Clin. Oncol., 16: 3121-3128, 1998.
11. Lockett, M. A., Baron, P. L., O'Brien, P. H., Elliott, B. M., Robison, J. G., Maitre, N., Metcalf, J. S., and Cole, D. J. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J. Am. Coll. Surg., 187: 9-16, 1998.
12. Lockett, M. A., Metcalf, J. S., Baron, P. L., O'Brien, P. H., Elliott, B. M., Robison, J. G., and Cole, D. J. Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients. Am. Surg., 64: 539-543, discussion 543-544, 1998.
13. Molina, R., Jo, J., Filella, X., Zanon, G., Pahisa, J., Munoz, M., Farrus, B., Latre, M. L., Escriche, C., Estape, J., and Ballesta, A. M. C-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value. Breast Cancer Res. Treat., 51: 109-119, 1998.
14. Pathak, K. A., Khanna, R., Khanna, H. D., Khanna, S., Gupta, S., and Khanna, N. N. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer. J. Postgrad. Med., 42: 68-71, 1996.
15. Rosenberg, R., Gertler, R., Friederichs, J., Fuehrer, K., Dahm, M., Phelps, R., Thorban, S., Nekarda, H., and Siewert, J. R. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry, 49: 150-158, 2002.
16. Hsu, S. M., Raine, L., and Fanger, H. Use of avidin-biotin immunoperoxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (pap) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
17. Mitas, M., Mikhitarian, K., Walters, C., Baron, P. L., Elliott, B. M., Brothers, T. E., Robison, J. G., Metcalf, J. S., Palesch, Y. Y., Zhang, Z., Gillanders, W. E., and Cole, D. J. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int. J. Cancer, 93: 162-171, 2001.
18. Mitas, M., Mikhitarian, K., Hoover, L., Lockett, M. A., Kelley, L., Hill, A., Gillanders, W. E., and Cole, D. J. Prostate-specific ets (pse) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodes. Br. J. Cancer, 86: 899-904, 2002.
19. Muller, P. Y., Janovjak, H., Miserez, A. R., and Dobbie, Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques, 32: 1372-1374, 1376, 1378-1379, 2002.
20. de Cremoux, P., Extra, J. M., Denis, M. G., Pierga, J. Y., Bourstyn, E., Nos, C., Clough, K. B., Boudou, E., Martin, E. C., Muller, A., Pouillart, P., and Magdelenat, H. Detection of muc1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. Clin. Cancer Res., 6: 3117-3122, 2000.
21. Lopez-Guerrero, J. A., Bolufer-Gilabert, P., Sanz-Alonso, M., Barragan-Gonzalez, E., Palau-Perez, J., De la Rubia-Comos, J., Sempere-Talens, A., and Bonanad-Boix, S. Minimal illegitimate levels of cytokeratin k19 expression in mononucleated blood cells detected by a reverse transcription PCR method (RT-PCR). Clin. Chim. Acta, 263: 105-116, 1997.
22. Houghton, R., Dillon, D., Molesh, D., Zehentner, B., Xu, J., Jiang, J., Schmidt, C., Frudakis, A., Repasky, E., Filho, A., Nolasco, M., Badaro, R., Zhang, X., Roche, P., Persing, D., and Reed, S. Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells. Mol. Diagn., 6: 79-91, 2001.
23. Zach, O., Kasparu, H., Krieger, O., Hehenwarter, W., Girschikofsky, M., and Lutz, D. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J. Clin. Oncol., 17: 2015-2019, 1999.
24. Smith, B. M., Slade, M. J., English, J., Graham, H., Luchtenborg, M., Sinnett, H. D., Cross, N. C., and Coombes, R. C. Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. J. Clin. Oncol., 18: 1432-1439, 2000.
25. Soria, J. C., Gauthier, L. R., Raymond, E., Granotier, C., Morat, L., Armand, J. P., Boussin, F. D., and Sabatier, L. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. Clin. Cancer Res., 5: 971-975, 1999.
26. Martell, M., Gomez, J., Esteban, J. I., Sauleda, S., Quer, J., Cabot, B., Esteban, R., and Guardia, J. High-throughput real-time reverse transcfiption-pcr quantitation of hepatitis C virus RNA. J. Clin. Microbiol., 37: 327-332, 1999.
27. Bieche, I., Olivi, M., Champeme, M. H., Vidaud, D., Lidereau, R., and Vidaud, M. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int. J. Cancer, 78: 661-666, 1998.
28. Hardingham, J. E., Kotasek, D., Farmer, B., Butler, R. N., Mi, J. X., Sage, R. E., and Dobrovic, A. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res., 53: 3455-3458, 1993.
29. Denis, M. G., Lipart, C., Leborgne, J., LeHur, P. A., Galmiche, J. P., Denis, M., Ruud, E., Truchaud, A., and Lustenberger, P. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int. J. Cancer, 74: 540-544, 1997.
30. Naume, B., Borgen, E., Beiske, K., Herstad, T. K., Ravnas, G., Renolen, A., Trachsel, S., Thrane-Steen, K., Funderud, S., and Kvalheim, G. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J. Hematother., 6: 103-114, 1997.
31. Eaton, M. C., Hardingham, J. E., Kotasek, D., and Dobrovic, A. Immunobead RT-PCR: a sensitive method for detection of circulating tumor cells. Biotechniques, 22: 100-105, 1997.
32. Zhong, X. Y., Kaul, S., Lin, Y. S., Eichler, A., and Bastert, G. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19. J. Cancer Res. Clin. Oncol., 126: 212-218, 2000.